MAPT and Alzheimer disease: CSF examination showed levels of neurodegeneration marker proteins within the normal ranges for the local laboratory (total tau 321 pg/mL, beta-amyloid1-42 957 pg/mL, ratio tau:amyloid 0.34), making a diagnosis of underlying Alzheimer’s disease pathology unlikely.